Older Australians face a "really tough" decision about whether to get the AstraZeneca vaccine, with one expert saying it is a trade-off between individual and community benefits.
The AstraZeneca vaccine is being rolled out to Australia's over 50s community, with experts saying the risk of getting COVID-19 outweighed the risk of rare but possibly deadly blood clots.
However, many in the community are concerned about getting blood clots after 18 cases of thrombosis with thrombocytopenia syndrome (TTS) linked to the AstraZeneca vaccine were discovered in Australia. One person has died so far, with 1.8 million doses administered.
Experts are still recommending over 50s get the jab because the risk of serious complications from AstraZeneca is "infinitesimally small" for this age group, Dr Ian Gemmell, the West Australian-born medical director of a large vaccination centre in Salisbury in the UK told the